Table 1 Open in new tab Temporal trends...

Year	Number of patients with AF (prevalence, %)^a	Oral anticoagulant, n (%)^b	Antiplatelet, n (%)^b
2009	16 158 (1.6)	999 (36.2)	2138 (47.5)	2330 (50.8)	2231 (51.8)	7698 (47.6)	791 (28.7)	1710 (38.0)	1796 (39.1)	1752 (40.6)	6049 (37.4)
2010	58 256 (1.7)	3543 (34.6)	7426 (46.7)	8392 (51.0)	8599 (54.9)	27 960 (48.0)	3118 (30.5)	6026 (37.9)	6333 (38.5)	5876 (37.5)	21 353 (36.7)
2011	163 101 (1.8)	8768 (33.9)	20 487 (47.3)	25 562 (53.5)	26 777 (57.9)	81 594 (50.0)	7840 (30.3)	16 023 (37.0)	17 183 (36.0)	16 089 (34.8)	57 135 (35.0)
2012	161 747 (1.8)	8432 (33.4)	20 389 (48.3)	26 484 (55.4)	28 030 (60.4)	83 335 (51.5)	7739 (30.6)	15 526 (36.8)	16 555 (34.6)	15 275 (32.9)	55 095 (34.1)
2013	61 055 (1.8)	3142 (33.3)	7827 (51.5)	10 651 (58.8)	11 571 (63.1)	33 191 (54.4)	2660 (28.2)	5186 (34.1)	5669 (31.3)	5565 (30.4)	19 080 (31.3)
2014	52 102 (2.0)	2897 (35.4)	7442 (56.9)	9946 (64.3)	10 435 (67.9)	30 720 (59.0)	1855 (22.7)	3686 (28.2)	3874 (25.1)	3896 (25.4)	13 311 (25.5)
2015	82 403 (2.2)	5289 (39.8)	13 185 (63.4)	16 994 (70.3)	17 981 (74.4)	53 449 (64.9)	2194 (16.5)	4354 (20.9)	4693 (19.4)	4640 (19.2)	15 881 (19.3)
2016	96 063 (2.1)	6469 (43.0)	16 047 (67.1)	20 647 (73.4)	22 460 (77.6)	65 623 (68.3)	1895 (12.6)	3904 (16.3)	4454 (15.8)	4587 (15.8)	14 840 (15.4)
2017	106 037 (2.1)	7382 (44.3)	18 637 (70.7)	23 885 (77.0)	25 850 (80.8)	75 754 (71.4)	1582 (9.5)	3233 (12.3)	3798 (12.2)	4093 (12.8)	12 706 (12.0)
2018	88 016 (2.4)	6237 (46.4)	16 374 (74.7)	20 951 (80.6)	22 420 (84.0)	65 982 (75.0)	1020 (7.6)	2089 (9.5)	2463 (9.5)	2551 (9.6)	8123 (9.2)

Year

Number of patients with AF (prevalence, %)^a

Oral anticoagulant, n (%)^b

Antiplatelet, n (%)^b

CHADS₂ score

Total

2009

16 158 (1.6)

999 (36.2)

2138 (47.5)

2330 (50.8)

2231 (51.8)

7698 (47.6)

791 (28.7)

1710 (38.0)

1796 (39.1)

1752 (40.6)

6049 (37.4)

2010

58 256 (1.7)

3543 (34.6)

7426 (46.7)

8392 (51.0)

8599 (54.9)

27 960 (48.0)

3118 (30.5)

6026 (37.9)

6333 (38.5)

5876 (37.5)

21 353 (36.7)

2011

163 101 (1.8)

8768 (33.9)

20 487 (47.3)

25 562 (53.5)

26 777 (57.9)

81 594 (50.0)

7840 (30.3)

16 023 (37.0)

17 183 (36.0)

16 089 (34.8)

57 135 (35.0)

2012

161 747 (1.8)

8432 (33.4)

20 389 (48.3)

26 484 (55.4)

28 030 (60.4)

83 335 (51.5)

7739 (30.6)

15 526 (36.8)

16 555 (34.6)

15 275 (32.9)

55 095 (34.1)

2013

61 055 (1.8)

3142 (33.3)

7827 (51.5)

10 651 (58.8)

11 571 (63.1)

33 191 (54.4)

2660 (28.2)

5186 (34.1)

5669 (31.3)

5565 (30.4)

19 080 (31.3)

2014

52 102 (2.0)

2897 (35.4)

7442 (56.9)

9946 (64.3)

10 435 (67.9)

30 720 (59.0)

1855 (22.7)

3686 (28.2)

3874 (25.1)

3896 (25.4)

13 311 (25.5)

2015

82 403 (2.2)

5289 (39.8)

13 185 (63.4)

16 994 (70.3)

17 981 (74.4)

53 449 (64.9)

2194 (16.5)

4354 (20.9)

4693 (19.4)

4640 (19.2)

15 881 (19.3)

2016

96 063 (2.1)

6469 (43.0)

16 047 (67.1)

20 647 (73.4)

22 460 (77.6)

65 623 (68.3)

1895 (12.6)

3904 (16.3)

4454 (15.8)

4587 (15.8)

14 840 (15.4)

2017

106 037 (2.1)

7382 (44.3)

18 637 (70.7)

23 885 (77.0)

25 850 (80.8)

75 754 (71.4)

1582 (9.5)

3233 (12.3)

3798 (12.2)

4093 (12.8)

12 706 (12.0)

2018

88 016 (2.4)

6237 (46.4)

16 374 (74.7)

20 951 (80.6)

22 420 (84.0)

65 982 (75.0)

1020 (7.6)

2089 (9.5)

2463 (9.5)

2551 (9.6)

8123 (9.2)

Year	Number of patients with AF (prevalence, %)^a	Oral anticoagulant, n (%)^b	Antiplatelet, n (%)^b
2009	16 158 (1.6)	999 (36.2)	2138 (47.5)	2330 (50.8)	2231 (51.8)	7698 (47.6)	791 (28.7)	1710 (38.0)	1796 (39.1)	1752 (40.6)	6049 (37.4)
2010	58 256 (1.7)	3543 (34.6)	7426 (46.7)	8392 (51.0)	8599 (54.9)	27 960 (48.0)	3118 (30.5)	6026 (37.9)	6333 (38.5)	5876 (37.5)	21 353 (36.7)
2011	163 101 (1.8)	8768 (33.9)	20 487 (47.3)	25 562 (53.5)	26 777 (57.9)	81 594 (50.0)	7840 (30.3)	16 023 (37.0)	17 183 (36.0)	16 089 (34.8)	57 135 (35.0)
2012	161 747 (1.8)	8432 (33.4)	20 389 (48.3)	26 484 (55.4)	28 030 (60.4)	83 335 (51.5)	7739 (30.6)	15 526 (36.8)	16 555 (34.6)	15 275 (32.9)	55 095 (34.1)
2013	61 055 (1.8)	3142 (33.3)	7827 (51.5)	10 651 (58.8)	11 571 (63.1)	33 191 (54.4)	2660 (28.2)	5186 (34.1)	5669 (31.3)	5565 (30.4)	19 080 (31.3)
2014	52 102 (2.0)	2897 (35.4)	7442 (56.9)	9946 (64.3)	10 435 (67.9)	30 720 (59.0)	1855 (22.7)	3686 (28.2)	3874 (25.1)	3896 (25.4)	13 311 (25.5)
2015	82 403 (2.2)	5289 (39.8)	13 185 (63.4)	16 994 (70.3)	17 981 (74.4)	53 449 (64.9)	2194 (16.5)	4354 (20.9)	4693 (19.4)	4640 (19.2)	15 881 (19.3)
2016	96 063 (2.1)	6469 (43.0)	16 047 (67.1)	20 647 (73.4)	22 460 (77.6)	65 623 (68.3)	1895 (12.6)	3904 (16.3)	4454 (15.8)	4587 (15.8)	14 840 (15.4)
2017	106 037 (2.1)	7382 (44.3)	18 637 (70.7)	23 885 (77.0)	25 850 (80.8)	75 754 (71.4)	1582 (9.5)	3233 (12.3)	3798 (12.2)	4093 (12.8)	12 706 (12.0)
2018	88 016 (2.4)	6237 (46.4)	16 374 (74.7)	20 951 (80.6)	22 420 (84.0)	65 982 (75.0)	1020 (7.6)	2089 (9.5)	2463 (9.5)	2551 (9.6)	8123 (9.2)

Table 1

Open in new tab

Temporal trends of the prescription of oral anticoagulants and antiplatelets for patients with AF by CHADS₂ score, 2009–2018

Year	Number of patients with AF (prevalence, %)^a	Oral anticoagulant, n (%)^b					Antiplatelet, n (%)^b
		CHADS₂ score					CHADS₂ score
		0	1	2	>2	Total	0	1	2	>2	Total
2009	16 158 (1.6)	999 (36.2)	2138 (47.5)	2330 (50.8)	2231 (51.8)	7698 (47.6)	791 (28.7)	1710 (38.0)	1796 (39.1)	1752 (40.6)	6049 (37.4)
2010	58 256 (1.7)	3543 (34.6)	7426 (46.7)	8392 (51.0)	8599 (54.9)	27 960 (48.0)	3118 (30.5)	6026 (37.9)	6333 (38.5)	5876 (37.5)	21 353 (36.7)
2011	163 101 (1.8)	8768 (33.9)	20 487 (47.3)	25 562 (53.5)	26 777 (57.9)	81 594 (50.0)	7840 (30.3)	16 023 (37.0)	17 183 (36.0)	16 089 (34.8)	57 135 (35.0)
2012	161 747 (1.8)	8432 (33.4)	20 389 (48.3)	26 484 (55.4)	28 030 (60.4)	83 335 (51.5)	7739 (30.6)	15 526 (36.8)	16 555 (34.6)	15 275 (32.9)	55 095 (34.1)
2013	61 055 (1.8)	3142 (33.3)	7827 (51.5)	10 651 (58.8)	11 571 (63.1)	33 191 (54.4)	2660 (28.2)	5186 (34.1)	5669 (31.3)	5565 (30.4)	19 080 (31.3)
2014	52 102 (2.0)	2897 (35.4)	7442 (56.9)	9946 (64.3)	10 435 (67.9)	30 720 (59.0)	1855 (22.7)	3686 (28.2)	3874 (25.1)	3896 (25.4)	13 311 (25.5)
2015	82 403 (2.2)	5289 (39.8)	13 185 (63.4)	16 994 (70.3)	17 981 (74.4)	53 449 (64.9)	2194 (16.5)	4354 (20.9)	4693 (19.4)	4640 (19.2)	15 881 (19.3)
2016	96 063 (2.1)	6469 (43.0)	16 047 (67.1)	20 647 (73.4)	22 460 (77.6)	65 623 (68.3)	1895 (12.6)	3904 (16.3)	4454 (15.8)	4587 (15.8)	14 840 (15.4)
2017	106 037 (2.1)	7382 (44.3)	18 637 (70.7)	23 885 (77.0)	25 850 (80.8)	75 754 (71.4)	1582 (9.5)	3233 (12.3)	3798 (12.2)	4093 (12.8)	12 706 (12.0)
2018	88 016 (2.4)	6237 (46.4)	16 374 (74.7)	20 951 (80.6)	22 420 (84.0)	65 982 (75.0)	1020 (7.6)	2089 (9.5)	2463 (9.5)	2551 (9.6)	8123 (9.2)

Year	Number of patients with AF (prevalence, %)^a	Oral anticoagulant, n (%)^b					Antiplatelet, n (%)^b
		CHADS₂ score					CHADS₂ score
		0	1	2	>2	Total	0	1	2	>2	Total
2009	16 158 (1.6)	999 (36.2)	2138 (47.5)	2330 (50.8)	2231 (51.8)	7698 (47.6)	791 (28.7)	1710 (38.0)	1796 (39.1)	1752 (40.6)	6049 (37.4)
2010	58 256 (1.7)	3543 (34.6)	7426 (46.7)	8392 (51.0)	8599 (54.9)	27 960 (48.0)	3118 (30.5)	6026 (37.9)	6333 (38.5)	5876 (37.5)	21 353 (36.7)
2011	163 101 (1.8)	8768 (33.9)	20 487 (47.3)	25 562 (53.5)	26 777 (57.9)	81 594 (50.0)	7840 (30.3)	16 023 (37.0)	17 183 (36.0)	16 089 (34.8)	57 135 (35.0)
2012	161 747 (1.8)	8432 (33.4)	20 389 (48.3)	26 484 (55.4)	28 030 (60.4)	83 335 (51.5)	7739 (30.6)	15 526 (36.8)	16 555 (34.6)	15 275 (32.9)	55 095 (34.1)
2013	61 055 (1.8)	3142 (33.3)	7827 (51.5)	10 651 (58.8)	11 571 (63.1)	33 191 (54.4)	2660 (28.2)	5186 (34.1)	5669 (31.3)	5565 (30.4)	19 080 (31.3)
2014	52 102 (2.0)	2897 (35.4)	7442 (56.9)	9946 (64.3)	10 435 (67.9)	30 720 (59.0)	1855 (22.7)	3686 (28.2)	3874 (25.1)	3896 (25.4)	13 311 (25.5)
2015	82 403 (2.2)	5289 (39.8)	13 185 (63.4)	16 994 (70.3)	17 981 (74.4)	53 449 (64.9)	2194 (16.5)	4354 (20.9)	4693 (19.4)	4640 (19.2)	15 881 (19.3)
2016	96 063 (2.1)	6469 (43.0)	16 047 (67.1)	20 647 (73.4)	22 460 (77.6)	65 623 (68.3)	1895 (12.6)	3904 (16.3)	4454 (15.8)	4587 (15.8)	14 840 (15.4)
2017	106 037 (2.1)	7382 (44.3)	18 637 (70.7)	23 885 (77.0)	25 850 (80.8)	75 754 (71.4)	1582 (9.5)	3233 (12.3)	3798 (12.2)	4093 (12.8)	12 706 (12.0)
2018	88 016 (2.4)	6237 (46.4)	16 374 (74.7)	20 951 (80.6)	22 420 (84.0)	65 982 (75.0)	1020 (7.6)	2089 (9.5)	2463 (9.5)	2551 (9.6)	8123 (9.2)

AF, atrial fibrillation.

Number (%) represents AF prevalence in overall population.

n (%) represents the proportion of oral anticoagulant/antiplatelet prescribing amongst patients with AF and corresponding CHADS₂ score.

This Feature Is Available To Subscribers Only